Cliff Keeling

Cliff Keeling is an accomplished healthcare and pharmaceutical sales leader with extensive experience in various high-impact roles across key organizations. Currently serving as the Regional Business Director for Intercept Pharmaceuticals since January 2024, Cliff has successfully re-organized and led a sales team focused on rare autoimmune liver diseases, significantly boosting regional performance. Prior experience includes roles at Inizio, Cogniwound, and Olaregen Therapeutix, where Cliff oversaw sales strategies, developed market access, and established key partnerships, contributing to substantial revenue growth. With a strong background in launching and commercializing innovative therapies, Cliff has consistently demonstrated the ability to build and lead successful teams, develop strategic business plans, and achieve remarkable sales results. Cliff holds a degree from the City University of New York-College of Staten Island.